A small study from an HIV hospital that has been conducting experimental treatment interruptions (ATIs) as part of research into achieving a functional cure for HIV infection has found that over a period of years, patients who had undergone ATIs had a higher risk of developing non-AIDS-related serious illnesses such as cancer, liver disease and kidney disease than a control group of patients who never interrupted their antiretroviral therapy (ART).
The study, by Dr Valèria Richart and colleagues from Barcelona University Hospital, included 146 patients who had taken part in ten studies involving ATIs and compared them to a similar group of 45 patients who had never had an ATI.
The study found that over a period of nearly 20 years, patients who had had an ATI were four times more likely to develop a serious non-AIDS-related event than ones who had not.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
-
TheBodyPro: Can long-acting regimens solve virologic failure in heavily treatment-experienced people with HIV?
-
[Press release] TaiMed Biologics completes Phase 2b enrollment for TMB-365/380 in HIV maintenance therapy study
-
Spotlight: South Africa’s ARV programme hardly grew in 2025, according to latest estimates
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.